Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Wednesday. The brokerage issued a hold rating on the stock.

Milestone Scientific Price Performance

MLSS stock opened at $0.56 on Wednesday. Milestone Scientific has a 52-week low of $0.52 and a 52-week high of $1.35. The firm has a market cap of $42.82 million, a P/E ratio of -5.59 and a beta of 0.97. The company’s 50-day simple moving average is $0.66 and its 200-day simple moving average is $0.70.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%. The business had revenue of $2.26 million during the quarter.

Institutional Investors Weigh In On Milestone Scientific

A hedge fund recently bought a new stake in Milestone Scientific stock. AE Wealth Management LLC acquired a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 27,936 shares of the company’s stock, valued at approximately $26,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.